The importance of SII and FIB-4 scores in predicting mortality in idiopathic pulmonary fibrosis patients

IF 2.5 3区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Clinical biochemistry Pub Date : 2024-07-06 DOI:10.1016/j.clinbiochem.2024.110789
Gorkem Berna Koyun , Serdar Berk , Omer Tamer Dogan
{"title":"The importance of SII and FIB-4 scores in predicting mortality in idiopathic pulmonary fibrosis patients","authors":"Gorkem Berna Koyun ,&nbsp;Serdar Berk ,&nbsp;Omer Tamer Dogan","doi":"10.1016/j.clinbiochem.2024.110789","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Quick and simple parameters are needed to predict mortality in patients with idiopathic pulmonary fibrosis (IPF). In this way, risky patients will have the opportunity to receive early and effective treatment. In this study, we examined whether the Fibrosis-4 index (FIB-4) and systemic immune inflammation index (SII) are associated with mortality in IPF patients.</p></div><div><h3>Materials and methods</h3><p>The study was designed retrospectively. 100 patients diagnosed with IPF were included in the study. Variables between living patients and deceased patients were examined.</p></div><div><h3>Results</h3><p>Out of a total of 100 patients, 67 were divided into the surviving group and 33 into the non-surviving group. In multivariate analysis, high FIB-4 and SII values were significantly associated with an increased risk of death.</p></div><div><h3>Conclusion</h3><p>FIB-4 and SII are parameters that can predict mortality in IPF patients. In this way, IPF patients with high mortality risk will be identified earlier and more effective methods will be used in follow-up and treatment.</p></div>","PeriodicalId":10172,"journal":{"name":"Clinical biochemistry","volume":"131 ","pages":"Article 110789"},"PeriodicalIF":2.5000,"publicationDate":"2024-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical biochemistry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0009912024000833","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Quick and simple parameters are needed to predict mortality in patients with idiopathic pulmonary fibrosis (IPF). In this way, risky patients will have the opportunity to receive early and effective treatment. In this study, we examined whether the Fibrosis-4 index (FIB-4) and systemic immune inflammation index (SII) are associated with mortality in IPF patients.

Materials and methods

The study was designed retrospectively. 100 patients diagnosed with IPF were included in the study. Variables between living patients and deceased patients were examined.

Results

Out of a total of 100 patients, 67 were divided into the surviving group and 33 into the non-surviving group. In multivariate analysis, high FIB-4 and SII values were significantly associated with an increased risk of death.

Conclusion

FIB-4 and SII are parameters that can predict mortality in IPF patients. In this way, IPF patients with high mortality risk will be identified earlier and more effective methods will be used in follow-up and treatment.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
SII 和 FIB-4 评分在预测特发性肺纤维化患者死亡率方面的重要性。
简介:需要快速、简单的参数来预测特发性肺纤维化(IPF)患者的死亡率。这样,高危患者就有机会尽早接受有效治疗。在这项研究中,我们检测了纤维化-4指数(FIB-4)和全身免疫炎症指数(SII)是否与IPF患者的死亡率相关:研究采用回顾性设计。研究纳入了 100 名确诊为 IPF 的患者。结果:在总共 100 例患者中,有 1 例死亡:结果:在总共 100 名患者中,67 人被分为存活组,33 人被分为非存活组。在多变量分析中,FIB-4 和 SII 值越高,死亡风险越大:结论:FIB-4和SII是可以预测IPF患者死亡率的参数。结论:FIB-4 和 SII 是可以预测 IPF 患者死亡率的参数,这样就能更早地发现有高死亡风险的 IPF 患者,并在随访和治疗中采用更有效的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical biochemistry
Clinical biochemistry 医学-医学实验技术
CiteScore
5.10
自引率
0.00%
发文量
151
审稿时长
25 days
期刊介绍: Clinical Biochemistry publishes articles relating to clinical chemistry, molecular biology and genetics, therapeutic drug monitoring and toxicology, laboratory immunology and laboratory medicine in general, with the focus on analytical and clinical investigation of laboratory tests in humans used for diagnosis, prognosis, treatment and therapy, and monitoring of disease.
期刊最新文献
Establishing sustainable quality improvement in the clinical laboratory: Redesign of the total testing process and digital transformation of routine quality assurance activities. Therapeutic drug monitoring of levetiracetam – Is dried blood spot sampling suitable? The case of a bloody mess - Bictegravir/emtricitabine/tenofovir alafenamide induced colitis. The pitfalls and significance of using ratios and calculated parameters in laboratory medicine. Assessment of accuracy, clinical validity, and analytical linearity in point-of-care glucose monitoring devices for diabetes mellitus: A systematic review and meta-analysis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1